rs869320686
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PS3_SupportingPP3PM2_SupportingPS2PS4_Moderate
This summary comes from the ClinGen Evidence Repository: The NM_006767.4:c.742G>A (p.Gly248Arg) variant in LZTR1 is a missense variant predicted to cause substitution of glycine by arginine at amino acid 248. Evidence supports that this variant is associated with AD NS and is not associated with AR NS. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.839, which is above the threshold of 0.7, evidence that correlates with impact to LZTR1 function (PP3). ERK1/2 phosphorylation assays in HEK293 cells showed enhanced EGF-dependent ERK1/2 phosphorylation indicating that this variant impacts protein function (PMID:30481304)(PS3_Supporting). This variant has been reported in 3 probands with features of RASopathy (PS4_Moderate; PMID:25795793, 30859559, 31533111). This variant has been identified as a de novo occurrence with confirmed parental relationships in 1 individual with features of RASopathy (PS2; PMID:30859559). Schwannomatosis has not been observed in individuals harboring this variant. In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal dominant RASopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: PS2, PS4_Moderate, PS3_Supporting, PM2_Supporting, PP3. (RASopathy VCEP specifications version 1.1; 9/17/2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA358852/MONDO:0021060/094
Frequency
Consequence
NM_006767.4 missense
Scores
Clinical Significance
Conservation
Publications
- LZTR1-related schwannomatosisInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Noonan syndrome 10Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- schwannomatosisInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Noonan syndromeInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 2Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp
- breast cancerInheritance: AD Classification: MODERATE Submitted by: G2P
- Costello syndromeInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome with multiple lentiginesInheritance: AD, AR Classification: NO_KNOWN Submitted by: ClinGen
- cardiofaciocutaneous syndromeInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
- Noonan syndrome-like disorder with loose anagen hairInheritance: AR, AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006767.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LZTR1 | MANE Select | c.742G>A | p.Gly248Arg | missense | Exon 8 of 21 | ENSP00000496779.1 | Q8N653 | ||
| LZTR1 | c.742G>A | p.Gly248Arg | missense | Exon 8 of 21 | ENSP00000558088.1 | ||||
| LZTR1 | c.742G>A | p.Gly248Arg | missense | Exon 8 of 21 | ENSP00000558091.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 251070 AF XY: 0.00
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461616Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727090 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at